//www.makeeyeware.comInsight
//www.makeeyeware.comTaplow
//www.makeeyeware.comKnowledge
  • News
  • Cases
  • Downloads
01.11.2016

Taplow Attends Technology Fair in Copenhagen, Denmark

Taplow Denmark and Germany recently attended a Robotics Technology Fair in Copenhagen, Denmark. This joint initiative was developed to enable both...
01.11.2016

New Taplow Partners

Taplow Norway are delighted to introduce Lars Hoel, he joins to widen their ability to service the Retail and Luxury goods sectors, he joins...
01.11.2016

Expo Real - The European Real Estate Conference

彼得•Knobich史蒂夫群落和马克弗斯(T)aplow have just returned from attending the 2016 ExpoReal exhibition and conference in Munich,...
First 11 12 13 14 15 16 17 18 19 20

CEO FOR A SPORTS:

Situation: A Finnish, mainly nationally operating sports company needed new CEO as the old one was about to retire. As sports business is one of the competence areas of our Finnish partner, we ended up delivering this search.

Read more …

For further Information please contacTimo Toivanen, Finland

CEO FOR LOGISTICS:

Situation: One of the largest globally operating Logistics companies was in a need of new CIO for Finland. As Logistics and Value Chain is one of the competence areas of our Finnish partner, we ended up delivering this search.

Read more …

For further Information please contacTimo Toivanen, Finland

White Papers
  • India – The new R&D hub for Automotive

    Taplow India have conducted an in-depth review of the Automotive sector in India, For further information contactSangeeta Sabharwal, India

    Click Here
  • Maysam Rizvi reviews the Banking Tech Revolution.

    Capital is more expensive, costs are higher and prices have gone down… the technology revolution has become a necessity.

    Click Here
  • EVOLVING BUSINESS UNITS Market Access thus becoming “transversal”

    The pharmaceutical market, in regards to the price component covered by the NHS, has been, until today, characterised by the presence of drugs of high therapeutic value, such as cancer-drugs, rheumatologic drugs, anti-infection drugs and drugs for the treatment of chronic illnesses, the vast majority of which have either seen their patent expire recently or will see it expire in the next two years.

    Click Here
  • BUSINESS CYCLES

    人力资本提供了机遇和挑战:

    Click Here